Risedronate Sodium Tablet, Film Coated
Product Images NDC 59762-0406
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Risedronate Sodium (NDC 59762-0406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Risedronate Sodium Tabs 35 mg 150 mg 02)
Figure 2 (Risedronate Sodium Tabs 35 mg 150 mg 03)
Figure 3 (Risedronate Sodium Tabs 35 mg 150 mg 04)
Figure 4 (Risedronate Sodium Tabs 35 mg 150 mg 05)
Figure 5 (Risedronate Sodium Tabs 35 mg 150 mg 06)
Figure 6 (Risedronate Sodium Tabs 35 mg 150 mg 07)
Principal Display Panelndc 59762-0405-4dispense The Enclosed Medication Guide To Each Patientgreenstone® Brand4 Week Supply (4 Tablets) Once-a-week 4 Tabletsrisedronate Sodium Tablets35 mgrx Only (Risedronate Sodium Tabs 35 mg 150 mg 08)
Principal Display Panelndc 59762-0406-1dispense The Enclosed Medication Guide To Each Patientgreenstone® Brandone Month Pack (1 Tablet) Once-a-month 1 Tabletrisedronate Sodium Tablets150 mgrx Only (Risedronate Sodium Tabs 35 mg 150 mg 09)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.